Article

What We Learned About COPD in 2015

Chronic obstructive pulmonary disease (COPD) can cause irreversible lung damage, but researchers have found pivotal discoveries to help the incurable condition over the past 12 months.

Chronic obstructive pulmonary disease (COPD) can cause irreversible lung damage, but researchers have found pivotal discoveries to help the incurable condition over the past 12 months.

COPD is accompanied with uncomfortable shortness of breath and wheezing, among other symptoms. The Centers for Disease Control and Prevention (CDC) says that about 15 million Americans live with COPD, however, many people do not even know that they have the condition.

Read on to catch up on the key COPD findings in 2015, and stay up-to-date with the MD Magazine COPD condition center.

If post-bronchodilator spirometry is required for the diagnosis of chronic obstructive pulmonary disease (COPD), why doesn’t every single primary care physician do it?

Continue reading this story.

Imagine if there was a wallet-friendly rehabilitation strategy for patients with chronic obstructive pulmonary disease (COPD) that provides the same benefits as standard care. Well, you can stop imagining and see it for yourself.

Continue reading this story.

The onset of chronic obstructive pulmonary disease (COPD) may be dictated by inflammatory processes in the lung tissue, according to findings published in the journal Oncotarget.

Continue reading this story.

Age-standardized death rates are continuing to drop in the United States, according to an American Cancer Society (ACS) researchers’ study published online in JAMA. The only exception was in chronic obstructive pulmonary disease (COPD) which increased.

Continue reading this story.

Chronic obstructive pulmonary disease (COPD) can majorly limit physical activity and impair quality of life. A system believed to predict activity level proved to not be helpful at all.

Continue reading this story.

The MD Magazine Peer Exchange “Expanding Treatment Options: The Latest Developments in COPD Therapy” features a panel of physician experts discussing key topics in COPD therapy, including risk factors, personalized treatment, preventive measures, new combination therapies, and more.

Watch the discussion here.

Chronic obstructive pulmonary disease (COPD) can come with many co-morbidities. A recent study found that patients with COPD who are depressed are more likely to be readmitted to the hospital for acute exacerbation of their COPD.

Continue reading this story.

Physical activity declines over time in patients with chronic obstructive pulmonary disease (COPD), independent of disease severity. This decline is also associated with worsening lung function and loss of quality of life and health status.

Continue reading this story.

An unlikely remedy, beetroot juice, was found to improve chronic obstructive pulmonary disease (COPD) patients’ exercise performance.

Continue reading this story.

Computed tomography (CT) may be a better tool for diagnosing chronic obstructive pulmonary disease (COPD) and the frequent comorbidity pulmonary hypertension (PH) than the conventional method of using pulmonary function tests (PFTs).

Continue reading this story.

While chronic obstructive pulmonary disease (COPD) is linked to an increased risk of death from cardiovascular disease, it is not associated with the likelihood of stroke or systemic embolism, according to findings presented at the American Thoracic Society (ATS 2015) meeting in Denver, Colorado.

Continue reading this story.

A vitamin D deficiency makes chronic obstructive pulmonary disease (COPD) worse, according to Nele Heulens, of Katholieke Universiteit Leuven in Belgium, and several colleagues.

Continue reading this story.

Children with pneumonia have an increased risk of developing COPD and decreased lung-function, according to Lystra Hayden, MD, and colleagues.

Continue reading this story.

A review published online in Respiratory Research proposed a 5-step approach aimed at preventing fractures in chronic obstructive pulmonary disease (COPD) patients.

Continue reading this story.

Related Videos
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Use of Vaping Among Students, Conversations About Vaccines
Pavel Strnad, MD | Credit: RWTH Aachen
Janelle Bludhorn, MS, PA-C: How Common Medications Are Impacted by Extreme Heat
How to Screen for Heat-Related Illness Risks, with Janelle Bludhorn, MS, PA-C
A panel of 3 experts on COPD
A panel of 3 experts on COPD
© 2024 MJH Life Sciences

All rights reserved.